article thumbnail

A new era in diagnostics: The growing demand for POC testing

Pharmaceutical Technology

“For strip devices, you have just a few processes for the device assembly,” says Jean-François Bauer, head of marketing and business development at Mikron Automation. “In In molecular devices, you have a lot of processes, and they are very complex because you are dealing with different reagents and with a variety of materials.

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Clinical trials technology company Saama has hired Dr Clinton White as its new chief delivery officer. Drawing on 25 years in clinical research, White will oversee Saama’s project delivery teams. Pharmaceutical supplier PBSC has tapped Jose Ruiz as the new president and general manager for its US office.

article thumbnail

Expert view: What’s next for cell and gene therapy?

Drug Discovery World

Investment landscape In 2023, Matthieu de Kalbermatten, CEO of CellProthera, looks forward to presenting the final safety and efficacy results of the company’s Phase II clinical trial, and for moving into Phase III. Lending to the time-to-clinic discrepancy, we also see increasing demands on manufacturing capacity for CGT reagents.”

article thumbnail

Savran Technologies Inc. Rare Cell Detection Platform Contributes to Successful Clinical Trial for Detecting Breast Cancer Recurrence

The Pharma Data

A paper on the clinical trial results published in JAMA Oncology demonstrates the effectiveness of Savran Tech’s CTC detection technology with real world patients. BOSTON–( BUSINESS WIRE )– Savran Technologies Inc., BOSTON–( BUSINESS WIRE )– Savran Technologies Inc., About This Clinical Trial.

article thumbnail

GenScript expands capacity for cell and gene therapy programmes

Drug Discovery World

The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials. The company’s new Zhenjiang, China cGMP facility is scheduled to open in 2023. . “We

article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E.